NAVIDEA BIOPHARMACEUTICALS, INC. Increase Decrease In Operating Lease Liability
NAVIDEA BIOPHARMACEUTICALS, INC. reported Increase Decrease In Operating Lease Liability of -$27.09 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2023-11-14
- NAVIDEA BIOPHARMACEUTICALS, INC. increase decrease in operating lease liability for the quarter ending 2023-09-30 was -$8.87K.
- NAVIDEA BIOPHARMACEUTICALS, INC. increase decrease in operating lease liability for the quarter ending 2023-06-30 was -$9.24K.
- NAVIDEA BIOPHARMACEUTICALS, INC. increase decrease in operating lease liability for the quarter ending 2023-03-31 was -$8.99K.
- NAVIDEA BIOPHARMACEUTICALS, INC. increase decrease in operating lease liability for the quarter ending 2022-12-31 was -$8.75K.
- NAVIDEA BIOPHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2022 was -$275.72K.
- NAVIDEA BIOPHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2021 was -$294.95K.
- NAVIDEA BIOPHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2020 was -$260.53K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$8.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$18.11K derived: sum of 2 quarters · filed 2023-11-14 | -$27.09K 10-Q · filed 2023-11-14 | -$35.84K derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | -$9.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$18.23K 10-Q · filed 2023-08-11 | -$26.98K derived: sum of 3 quarters · filed 2023-08-11 | -$118.41K derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | -$8.99K 10-Q · filed 2023-05-11 | -$17.74K derived: sum of 2 quarters · filed 2023-05-11 | -$109.17K derived: sum of 3 quarters · filed 2023-11-14 | -$198.14K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | -$8.75K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$100.18K derived: sum of 2 quarters · filed 2023-11-14 | -$189.15K derived: sum of 3 quarters · filed 2023-11-14 | -$275.72K 10-K · filed 2023-03-27 |
| 2022-09-30 | -$91.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$180.40K derived: sum of 2 quarters · filed 2023-11-14 | -$266.97K 10-Q · filed 2023-11-14 | -$351.49K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$88.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$175.53K 10-Q · filed 2023-08-11 | -$260.05K derived: sum of 3 quarters · filed 2023-08-11 | -$313.85K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$86.57K 10-Q · filed 2023-05-11 | -$171.08K derived: sum of 2 quarters · filed 2023-05-11 | -$224.88K derived: sum of 3 quarters · filed 2023-05-11 | -$304.26K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$84.52K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$138.32K derived: sum of 2 quarters · filed 2023-03-27 | -$217.69K derived: sum of 3 quarters · filed 2023-03-27 | -$294.95K 10-K · filed 2023-03-27 |
| 2021-09-30 | -$53.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$133.18K derived: sum of 2 quarters · filed 2022-11-14 | -$210.43K 10-Q · filed 2022-11-14 | -$285.63K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$79.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$156.63K 10-Q · filed 2022-08-15 | -$231.83K derived: sum of 3 quarters · filed 2022-08-15 | -$277.37K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$77.26K 10-Q · filed 2022-05-16 | -$152.45K derived: sum of 2 quarters · filed 2022-05-16 | -$197.99K derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | -$75.19K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$120.73K derived: sum of 2 quarters · filed 2022-03-28 | -$260.53K 10-K · filed 2022-03-28 | |
| 2020-09-30 | -$45.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$185.34K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$139.80K 10-Q · filed 2021-08-12 |